Figure 4 (IMAGE)

Impact Journals LLC

Figure 4

Caption

Figure 4: Everolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts.

Credit

2023 Alam et al.

Usage Restrictions

Original Content

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.